TY  - CONF
AU  - Pasquau, Juan
AU  - López-Cortés, Luis
AU  - Mayorga, Maria Isabel
AU  - Viciana, Pompeyo
AU  - Arenas, María Del Mar
AU  - Ríos, Maria José
AU  - Hernández-Quero, José
AU  - Castaño, Manuel
AU  - Merino, María Dolores
AU  - Márquez, Manuel
AU  - Vergara, Antonio
AU  - Terrón, Alberto
AU  - Téllez, Francisco
AU  - Hidalgo-Tenorio, Carmen
PY  - 2014
UR  - http://hdl.handle.net/10668/1869
T2  - Journal of the International AIDS Society
AB  - INTRODUCTIONMonotherapy against HIV has undoubted theoretical advantages and has good scientific fundaments. However, it is still controversial and here we will analyze the efficacy and safety of MT with darunavir with ritonavir (DRV/r) on patients...
LA  - en
PB  - BioMed Central
KW  - Infecciones por VIH
KW  - Ritonavir
KW  - Sulfonamidas
KW  - Seguridad del Paciente
KW  - Estudios Retrospectivos
KW  - Medical Subject Headings::Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Thiazoles::Ritonavir
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Sulfonamides
KW  - Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Accidents::Accident Prevention::Safety::Patient Safety
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies
TI  - Monotherapy with darunavir/ritonavir is effective and safe in clinical practice.
TY  - conference presentation
ER  -